Axonics, Inc.
AXNXHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $366.4M | $273.7M | $180.3M | $111.5M | $13.8M | $707,000 |
| Operating income | −$26.1M | −$64.9M | −$71.8M | −$53.8M | −$80.6M | −$32.1M |
| Net income | −$6.1M | −$59.7M | −$80.1M | −$54.9M | −$79.9M | −$32.5M |
| Total assets | $719.9M | $659.4M | $547.9M | $342.2M | $219.8M | $171.9M |
| Total liabilities | $82.4M | $89.2M | $65.5M | $54.8M | $36.8M | $28.6M |
| Equity | $637.6M | $570.1M | $482.4M | $287.4M | $183.0M | $143.3M |
| EPS (diluted) | $-0.12 | $-1.28 | $-1.86 | $-1.48 | $-2.80 | — |
| Shares out. | 50.0M | 47.0M | 41.5M | 34.3M | 27.8M | 27.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −7.1%
- Net margin
- −1.7%
- Return on equity
- −1.0%
- Return on assets
- −0.8%
- Return on capital (ROCE)
- −3.9%
- Liabilities / assets
- 11.4%
- Debt / equity
- 0.13×
- Book value / share
- $12.76
- Revenue growth (YoY)
- 33.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- 10.22safe
- Accruals / assets
- −0.6%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 warning● 4 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kiernan Jane EDirector | Nov 15, 2024 | D | 19,861 | $71.00 |
| Woock JohnOfficer — EVP, Chief Mktg/Strtgy Officer | Nov 15, 2024 | D | 77,403 | $71.00 |
| Snyderman Nancy Lynn MdDirector | Nov 15, 2024 | D | 14,944 | $71.00 |
| Sama RindaOfficer — Chief Operating Officer | Nov 15, 2024 | D | 83,854 | $71.00 |
| Noblett KarenOfficer — Chief Medical Officer | Nov 15, 2024 | D | 34,428 | $71.00 |
| Mcnamara RobertDirector | Nov 15, 2024 | D | 14,861 | $71.00 |
| Lopez EstebanDirector | Nov 15, 2024 | D | 6,600 | $71.00 |
| Keese Kari LeighOfficer — Chief Financial Officer | Nov 15, 2024 | D | 40,362 | $71.00 |
| Ford Alfred J JrOfficer — Chief Commercial Officer | Nov 15, 2024 | D | 43,450 | $71.00 |
| Demski David MDirector | Nov 15, 2024 | D | 9,542 | $71.00 |
| Cohen Raymond WOfficer — Chief Executive Officer | Nov 15, 2024 | D | 292,731 | $71.00 |
| Carrel Michael HDirector | Nov 15, 2024 | D | 17,861 | $71.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 15, 2024
- Results of operationsNov 7, 2024
- Results of operationsAug 1, 2024
- Results of operationsApr 30, 2024
- Other material eventApr 4, 2024
- Shareholder vote · Other material eventMar 25, 2024
- Results of operationsFeb 28, 2024
- Entered a material agreement · Director / officer changeJan 8, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15Nov 25, 2024
- EFFECTNov 20, 2024
- 25-NSENov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
- 4PRIMARY DOCUMENTNov 15, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.